Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 926.00
-25.00 (-2.63%)
At close: Feb 20, 2025
TPE:6919 Revenue
In the year 2024, Caliway Biopharmaceuticals had annual revenue of 44.43M TWD with 14.13% growth. Caliway Biopharmaceuticals had revenue of 9.36M in the quarter ending December 31, 2024, a decrease of -37.19%.
Revenue
44.43M
Revenue Growth
+14.13%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
143.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |
| Center Laboratories | 1.57B |